NCT02243683View on ClinicalTrials.gov

Safety Study of Immune System Modulator for Autoimmune Diseases

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

March 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

AX-024.HCl

OTHER

Placebo

Trial Locations (1)

CF48 4DR

Simbec Research Ltd, Merthyr Tydfil

Sponsors

Collaborators (1)

ORION Clinical Services
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

collaborator

ORION Clinical Services

INDUSTRY

collaborator

Packaging Coordinators Inc

OTHER

collaborator

Centro de Biología Molecular Severo Ochoa, Spain (CBMSO)

UNKNOWN

lead

Artax Biopharma Inc

INDUSTRY